XML 38 R21.htm IDEA: XBRL DOCUMENT
v3.10.0.1

STOCKHOLDERS' EQUITY | 12 Months Ended
--- | ---
Dec. 31, 2018
Equity [Abstract] |
STOCKHOLDERS' EQUITY |
(13) | STOCKHOLDERS’ EQUITY
Common Stock The number of authorized and issued common stock and preferred stock are as follows:
|  | Successor |
|  | December 31, |  |  | December 31, |
|  | 2018 |  |  | 2017 |
Common stock shares authorized |  |  | 125,000,000 |  |  |  | 125,000,000 |
Common stock par value |  | $ | 0.001 |  |  | $ | 0.001 |
Common stock shares issued |  |  | 36,978,280 |  |  |  | 22,115,916 |
Preferred stock shares authorized |  |  | 3,000,000 |  |  |  | 3,000,000 |
Preferred stock par value |  | No par |  |  | No par |
Preferred stock shares issued |  |  | — |  |  |  | — |
Common Stock Repurchases No shares were repurchased during the twelve months ended December 31, 2018, the period from August 1, 2017 through December 31, 2017, the period from April 1, 2017 through July 31, 2017 and the twelve months ended March 31, 2017. Dividend Program There were no dividends declared during the twelve months ended December 31, 2018, the period from August 1, 2017 through December 31, 2017, the period from April 1, 2017 through July 31, 2017 and the twelve months ended March 31, 2017. Warrants During 2017, we issued 11,543,814 New Creditor Warrants upon emergence from bankruptcy to General Unsecured Creditors and for unresolved sale leaseback claims. In addition, 2,432,432 Series A Warrants and 2,629,657 Series B Warrants were issued to the holders of Predecessor stock with exercise prices of $57.06 and $62.28, respectively. As of December 31, 2018, we had 2,220,857 shares of common stock issuable upon the exercise of the New Creditor Warrants. No Series A Warrants or Series B Warrants have been exercised. In conjunction with the merger with GulfMark, approximately 2.3 million $0.01 Creditor Warrants (“GLF Creditor Warrants”) and approximately 0.8 million $100 Equity Warrants (“GLF Equity Warrants”) were assumed from GulfMark with each warrant becoming exercisable for 1.10 shares of Tidewater common stock on substantially the same terms and conditions as provided in the warrant agreements governing the GLF Creditor Warrants and the GLF Equity Warrants. As of December 31, 2018, we had 2,189,709 shares of common stock issuable upon the exercise of the GLF Creditor Warrants. No GLF Equity Warrants have been exercised. Accumulated Other Comprehensive Loss The changes in accumulated other comprehensive income by component, net of tax, are as follows:
|  | Successor |
|  | For the year ended December 31, 2018 |
(in thousands) |  | Balance at 12/31/17 |  |  | Gains/(losses) recognized in OCI |  | Reclasses from OCI to net income |  |  | Net period OCI |  |  | Remaining balance 12/31/18 |
Available for sale securities |  |  | 256 |  |  |  | (660 | ) |  |  |  | 404 |  |  |  | (256 | ) |  |  | — |
Pension/Post-retirement benefits |  |  | (403 | ) |  |  | 4,133 |  |  |  |  | (1,536 | ) |  |  | 2,597 |  |  |  | 2,194 |
Total |  |  | (147 | ) |  |  | 3,473 |  |  |  |  | (1,132 | ) |  |  | 2,341 |  |  |  | 2,194 |
|  | Successor |
|  | Period from August 1, 2017 through December 31, 2017 |
(in thousands) |  | Balance at 7/31/17 |  |  | Gains/(losses) recognized in OCI |  | Reclasses from OCI to net income |  |  | Net period OCI |  |  | Remaining balance 12/31/17 |
Available for sale securities |  |  | — |  |  |  | 87 |  |  |  |  | 169 |  |  |  | 256 |  |  |  | 256 |
Pension/Post-retirement benefits |  |  | — |  |  |  | (403 | ) |  |  |  | — |  |  |  | (403 | ) |  |  | (403 | )
Total |  |  | — |  |  |  | (316 | ) |  |  |  | 169 |  |  |  | (147 | ) |  |  | (147 | )
|  | Predecessor |
|  | Period from April 1, 2017 through July 31, 2017 |
(in thousands) |  | Balance at 3/31/17 |  |  | Gains/(losses) recognized in OCI |  | Reclasses from OCI to net income |  |  | Net period OCI |  |  | Remaining balance 7/31/17 |
Available for sale securities |  |  | (95 | ) |  |  | 57 |  |  |  |  | 106 |  |  |  | 163 |  |  |  | 68 |
Currency translation adjustment |  |  | (9,811 | ) |  |  | — |  |  |  |  | — |  |  |  | — |  |  |  | (9,811 | )
Pension/Post-retirement benefits |  |  | (438 | ) |  |  | (2,598 | ) |  |  |  | — |  |  |  | (2,598 | ) |  |  | (3,036 | )
Total |  |  | (10,344 | ) |  |  | (2,541 | ) |  |  |  | 106 |  |  |  | (2,435 | ) |  |  | (12,779 | )
|  | Predecessor |
|  | For the year ended March 31, 2017 |
(in thousands) |  | Balance at 3/31/16 |  |  | Gains/(losses) recognized in OCI |  | Reclasses from OCI to net income |  |  | Net period OCI |  |  | Remaining balance 3/31/17 |
Available for sale securities |  |  | (208 | ) |  |  | (265 | ) |  |  |  | 378 |  |  |  | 113 |  |  |  | (95 | )
Currency translation adjustment |  |  | (9,811 | ) |  |  | — |  |  |  |  | — |  |  |  | — |  |  |  | (9,811 | )
Pension/Post-retirement benefits |  |  | 4,683 |  |  |  | (5,121 | ) |  |  |  | — |  |  |  | (5,121 | ) |  |  | (438 | )
Interest rate swap |  |  | (1,530 | ) |  |  | — |  |  |  |  | 1,530 |  |  |  | 1,530 |  |  |  | — |
Total |  |  | (6,866 | ) |  |  | (5,386 | ) |  |  |  | 1,908 |  |  |  | (3,478 | ) |  |  | (10,344 | )
The following table summarizes the reclassifications from accumulated other comprehensive loss to the consolidated statement of income:
|  | Successor |  |  |  | Predecessor |  |  |
|  |  |  |  |  | Period from |  |  |  | Period from |  |  |  |  |  |  |
|  | Twelve Months |  |  | August 1, 2017 |  |  |  | April 1, 2017 |  |  | Twelve Months |  |  |
|  | Ended |  |  | through |  |  |  | through |  |  | Ended |  |  | Affected line item in the
(In thousands) |  | December 31, 2018 |  |  | December 31, 2017 |  |  |  | July 31, 2017 |  |  | March 31, 2017 |  |  | consolidated statements of income
Retiree medical plan |  | $ | (1,536 | ) |  |  | — |  |  |  |  | — |  |  |  | — |  |  | Interest income and other, net
Realized gains on available for sale securities |  |  | 404 |  |  |  | 169 |  |  |  |  | 106 |  |  |  | 582 |  |  | Interest and other debt costs
Interest rate swap |  |  | — |  |  |  | — |  |  |  |  | — |  |  |  | 2,353 |  |  | Interest and other debt costs
Total pre-tax amounts |  |  | (1,132 | ) |  |  | 169 |  |  |  |  | 106 |  |  |  | 2,935 |  |  |
Tax effect |  |  | — |  |  |  | — |  |  |  |  | — |  |  |  | 1,027 |  |  |
Total gains for the period, net of tax |  | $ | (1,132 | ) |  |  | 169 |  |  |  |  | 106 |  |  |  | 1,908 |  |  |
During the year ended March 31, 2017, $1.3 million ($2.4 million pre-tax) of remaining other comprehensive loss related to the interest rate swap, entered into in July 2010 in connection with the September 2010 senior notes offering, was recognized as interest expense in accordance with ASC 815.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration